| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.809 | 38.465 | 25.065 | 44.962 | 61.256 | 43.982 | 37.060 | 47.198 | 56.001 | 27.394 |
| Total Income - EUR | 40.809 | 38.465 | 25.284 | 45.348 | 62.046 | 44.264 | 37.060 | 47.198 | 56.001 | 27.394 |
| Total Expenses - EUR | 12.280 | 12.181 | 8.426 | 11.320 | 19.202 | 9.693 | 10.372 | 12.185 | 14.540 | 13.778 |
| Gross Profit/Loss - EUR | 28.529 | 26.284 | 16.858 | 34.028 | 42.844 | 34.572 | 26.688 | 35.013 | 41.461 | 13.617 |
| Net Profit/Loss - EUR | 27.304 | 25.515 | 16.605 | 33.574 | 42.226 | 33.982 | 26.492 | 34.550 | 40.912 | 11.283 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Viozenmedsan Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 44.415 | 27.897 | 18.862 | 35.340 | 42.880 | 34.507 | 27.096 | 35.274 | 45.215 | 14.542 |
| Inventories | 450 | 264 | 1.438 | 5.732 | 1.347 | 786 | 680 | 443 | 3.822 | 735 |
| Receivables | 15 | 15 | 15 | 15 | 548 | 103 | 113 | 68 | 39.877 | 294 |
| Cash | 43.949 | 27.617 | 17.409 | 29.594 | 40.986 | 33.618 | 26.303 | 34.763 | 1.516 | 13.513 |
| Shareholders Funds | 43.126 | 25.559 | 16.649 | 33.617 | 42.268 | 34.023 | 26.532 | 34.591 | 40.952 | 12.367 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.289 | 2.337 | 2.213 | 1.724 | 612 | 484 | 564 | 683 | 4.263 | 2.175 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Viozenmedsan Srl